• SENSEX 73,269.29
    -337.46 (--0.46%)
  • BANKNIFTY 54,366.70
    79.35 (+0.15%)
Back

Corporate News

Evonile Pharma seeks up to Rs 9,000 million via a rights issue to eligible shareholders
08-Oct-2026, 08:41

Evonile Pharma Limited, formerly known as Novartis India Limited, announced that its board approved a rights issue to raise up to Rs 9,000 million through the issuance of partly paid-up equity shares to eligible shareholders, subject to regulatory approvals. The company also formed a Rights Issue Committee consisting of Mr. Vikas Gupta, Dr. Jagriti Gupta, and Mr. Shashank Sinha to finalize the terms and conditions of the rights issue, and approved the adoption and launch of a new corporate website at www.evonilepharma.com.